Settlement clears way for Lilly to launch once-a-day insulin
The settlement with France-based Sanofi SA clears up uncertainty over a drug that could rack up more than $1 billion in sales by 2020, according to Wall Street analysts.
Health Care
Articles
Applications to Marian medical school keep rising
With the number of applications to Marian’s College of Osteopathic Medicine running twice as high as initially expected, school leaders say they are confident Marian can help reduce a looming physician shortage in Indiana.
Ball State trustees approve formation of College of Health
The new college's academic programs would include athletic training, nursing, speech pathology and psychology.
Purdue’s Chao Center regains drug, slashes $360-per-pill price
An Indiana not-for-profit has dropped the price of a drug for multi-drug resistant tuberculosis roughly 90 percent after re-acquiring rights to the medicine from Rodelis Therapeutics.
Lilly’s heart study sets up showdown with Novo’s Victoza
Unprecedented results from a cardiovascular study on a diabetes medicine sold by Eli Lilly and Co. turns up the pressure on rival Novo Nordisk, which will release data from a similar study on its competing drug next year.
Group urges Dems to tackle pharmaceutical prices
Pharmaceutical industry members are likely to dislike the proposal, which would require them disclose how much they spend on research and development, production, and sales and marketing.
Jardiance study lifts Lilly shares to 15-year high
Eli Lilly shares soared Thursday after study results showed Jardiance sharply reduced chances of dying in diabetic patients at high risk of heart complications. The study prompted at least one analyst to predict the drug could bring in billions of dollars by the end of the decade.
Lilly shares jump on latest data from diabetes drug
A diabetes pill called Jardiance sold by Eli Lilly and Co. cut deaths from heart attacks and strokes in thousands of patients, the first drug to show promise in helping subdue two of the world’s most rampant health epidemics.
FBI raids Carmel home of American Senior Communities CEO
The FBI conducted an investigation Tuesday morning at the Carmel home of James Burkhart, CEO of one of the state’s largest providers of nursing home care.
Drug-price increases slow as benefits managers get tough
A new analysis shows attempts by drugmakers to raise prices are being wiped out in negotiations with managers of drug insurance benefits like Express Scripts Holding Co. and CVS Health Corp.
Retail clinics, apps change doctor-patient relationship
A shortage of primary care physicians and emerging alternatives such as retail clinics and smartphone apps are changing the way patients access the U.S. health care system.
AMA: Anthem, Aetna deals threaten competition across nation
The market for health-insurance in the U.S. is already so highly concentrated that pending tie-ups among four of the country’s largest insurers risk hurting both consumers and doctors, the American Medical Association said.
More precise medical codes aim to track quality of care
On Oct. 1, the nation’s physicians and hospitals must start using a massive new coding system to describe your visit on insurance claims so they get paid.
IUPUI receives $1.9M grant for health workforce diversity
The grant will enable researchers at IU's Indianapolis medical campus to develop and implement the IU Health Careers Opportunity Program.
Senior housing planned on key 86th and Meridian corner
A Missouri-based development team wants to build a $10 million senior living center on the last available parcel at one of the north side’s most visible intersections.
Marian starts search for new med school dean
Marian University expects the deans of both its medical and nursing schools to retire in the next two years. So, the small Catholic school is launching a search for replacements.
Experimental osteoporosis drug bests Lilly’s Forteo in study
The experimental medicine, called romosozumab, showed better results than Eli Lilly and Co.’s Forteo after 12 months, Amgen and UCB said in a joint statement Wednesday.
Longtime IU Health leader Evans to retire next year
Daniel Evans Jr. plans to leave his post as president immediately and retire as CEO on May 1. The system’s chief operating officer, Dennis Murphy, will take over as president now and as CEO in the spring.
Novo Nordisk buying 2 DiMarchi-launched drug firms
Calibrium LLC and MB2 LLC, both based in Carmel, have agreed to be sold for undisclosed amounts. They were developing diabetes drugs discovered by the research team of Richard DiMarchi, a chemistry professor at Indiana University.
Lilly wins patent ruling over blockbuster drug Alimta
Eli Lilly and Co. won a court ruling that will keep generic versions of the chemotherapy drug Alimta off the U.S. market until a patent expires in 2022.